Skip to main content
Top
Published in: Lung 2/2003

01-05-2003

Proteolysis of Surfactant Protein D by Cystic Fibrosis Relevant Proteases

Authors: C. von Bredow, A. Wiesener, M. Griese

Published in: Lung | Issue 2/2003

Login to get access

Abstract

Surfactant protein D (SP-D) is an important innate host defense molecule that has been shown to interact with cystic fibrosis (CF)-associated pathogens. Previous studies demonstrated that rat SP-D is highly resistant to degradation by a wide range of proteolytic enzymes. The aim of this study was to examine whether human SP-D can be degraded by CF relevant proteases ex vivo and in vitro. Bronchoalveolar lavage fluids (BALFs) of 11 patients with CF in a stable clinical condition were examined for SP-D by immunoblotting. In vitro, purified human SP-D was treated with human leukocyte elastase, proteinase 3, cathepsin G or Pseudomonas elastase followed by immunoblotting with specific antibodies to SP-D. In BALF of 8 of the 11 patients investigated, proteolytic fragments or absence of SP-D were detected. In vitro proteolysis of SP-D was observed in a time-dependent manner for each protease applied. The presence of Ca++ at a physiologic concentration delayed, but did not prevent the degradation. We conclude that SP-D is an important target of numerous proteases present in the CF lung. Host defense is probably impaired due to proteolysis of SP-D and may contribute to the suppurative lung disease in CF.
Literature
1.
go back to reference Berger, M, Sorensen, RU, Tosi, MF, Dearborn, DG, Döring, G 1989Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis.J Clin Invest8413031313 Berger, M, Sorensen, RU, Tosi, MF, Dearborn, DG, Döring, G 1989Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis.J Clin Invest8413031313
2.
go back to reference Birrer, P, McElvaney, G, Rüdelberg, A, Wirz Sommer, C, Lichti-Gallati, S, Kraemer, R, Hubbard, R, Crystal, RG 1994Protease-Antiprotease imbalance in the lungs of children with cystic fibrosis.Am J Respir Crit Care Med151207213 Birrer, P, McElvaney, G, Rüdelberg, A, Wirz Sommer, C, Lichti-Gallati, S, Kraemer, R, Hubbard, R, Crystal, RG 1994Protease-Antiprotease imbalance in the lungs of children with cystic fibrosis.Am J Respir Crit Care Med151207213
3.
go back to reference Brown-Augsburger, P, Hartshorn, K, Chang, D, Rust, K, Fliszar, C, Welgus, HG, Crouch, EC 1996Site-directed mutagenesis of Cyst-15 and Cyst-20 of pulmonary surfactant protein D.J Biol Chem2711372413730CrossRefPubMed Brown-Augsburger, P, Hartshorn, K, Chang, D, Rust, K, Fliszar, C, Welgus, HG, Crouch, EC 1996Site-directed mutagenesis of Cyst-15 and Cyst-20 of pulmonary surfactant protein D.J Biol Chem2711372413730CrossRefPubMed
4.
go back to reference Bruce, MC, Poncz, L, Klinger, JD, Stern, RC, Tomashefski, JF, Dearborn, DG 1985Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis.Am Rev Respir Dis132529535PubMed Bruce, MC, Poncz, L, Klinger, JD, Stern, RC, Tomashefski, JF, Dearborn, DG 1985Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis.Am Rev Respir Dis132529535PubMed
5.
go back to reference Champagne, B, Tremblay, P, Cantin, A, Pierre, YS 1998Proteolytic cleavage of ICAM-1 by human neutrophil elastase.J Immunol16163986405PubMed Champagne, B, Tremblay, P, Cantin, A, Pierre, YS 1998Proteolytic cleavage of ICAM-1 by human neutrophil elastase.J Immunol16163986405PubMed
6.
go back to reference Crouch, EC 1998Structure, biological properties, and expression of surfactant protein D (SP-D).Biochem Biophys Acta1408278289CrossRefPubMed Crouch, EC 1998Structure, biological properties, and expression of surfactant protein D (SP-D).Biochem Biophys Acta1408278289CrossRefPubMed
7.
go back to reference Crouch, EC, Wright, JR 2001Surfactant proteins A and D and pulmonary host defense.Annu Rev Physiol63521554CrossRefPubMed Crouch, EC, Wright, JR 2001Surfactant proteins A and D and pulmonary host defense.Annu Rev Physiol63521554CrossRefPubMed
8.
go back to reference Dong, Q, Wright, JR 1998Degradation of surfactant protein D by alveolar macrophages.Am J Physiol214L97L105 Dong, Q, Wright, JR 1998Degradation of surfactant protein D by alveolar macrophages.Am J Physiol214L97L105
9.
go back to reference Döring, G, Frank, F, Boudier, C, Herbert, S, Fleischer, B, Bellon, G 1995Cleavage of lymphocyte surface antigens CD2, CD4 and CD8 by polymorphonuclear leukocyte elastase and cathepsin G in patients with cystic fibrosis.Am Assoc Immunol15448424850 Döring, G, Frank, F, Boudier, C, Herbert, S, Fleischer, B, Bellon, G 1995Cleavage of lymphocyte surface antigens CD2, CD4 and CD8 by polymorphonuclear leukocyte elastase and cathepsin G in patients with cystic fibrosis.Am Assoc Immunol15448424850
10.
go back to reference Griese, M, Birrer, P, Demirsoy, A 1997Pulmonary surfactant in cystic fibrosis.Eur Respir J1019831988CrossRefPubMed Griese, M, Birrer, P, Demirsoy, A 1997Pulmonary surfactant in cystic fibrosis.Eur Respir J1019831988CrossRefPubMed
11.
go back to reference Griese, M, von Bredow, C, Birrer, P 2001Reduced proteolysis of surfactant protein A and changes of the bronchoalveolar lavage fluid proteome by inhaled alpha 1-protease inhibitor in cystic fibrosis.Electrophoresis22165171CrossRefPubMed Griese, M, von Bredow, C, Birrer, P 2001Reduced proteolysis of surfactant protein A and changes of the bronchoalveolar lavage fluid proteome by inhaled alpha 1-protease inhibitor in cystic fibrosis.Electrophoresis22165171CrossRefPubMed
12.
go back to reference Khan, TZ, Wagner, JS, Bost, T, Martinez, J, Accuso, FJ, Riches, DW 1995Early pulmonary inflammation in infants with cystic fibrosis.Am J Respir Crit Care Med15110751082PubMed Khan, TZ, Wagner, JS, Bost, T, Martinez, J, Accuso, FJ, Riches, DW 1995Early pulmonary inflammation in infants with cystic fibrosis.Am J Respir Crit Care Med15110751082PubMed
13.
go back to reference Konstan, MW, Hilliard, KA, Norvell, TM, Berger, M 1995Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.Am J Respir Crit Care Med150448454 Konstan, MW, Hilliard, KA, Norvell, TM, Berger, M 1995Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.Am J Respir Crit Care Med150448454
14.
go back to reference Kuan, SF, Rust, K, Crouch, EC 1992Interactions of surfactant protein D with bacterial lipopolysaccharides. Surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage.J Clin Invest9097106PubMed Kuan, SF, Rust, K, Crouch, EC 1992Interactions of surfactant protein D with bacterial lipopolysaccharides. Surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage.J Clin Invest9097106PubMed
15.
go back to reference Liau, DF, Yin, NX, Huang, J, Ryan, SF 1996Effects of human polymorphonuclear leukocyte elastase upon surfactant in vitro.Biochem Biophys Acta1302117128PubMed Liau, DF, Yin, NX, Huang, J, Ryan, SF 1996Effects of human polymorphonuclear leukocyte elastase upon surfactant in vitro.Biochem Biophys Acta1302117128PubMed
16.
go back to reference Madan, T, Eggleton, P, Kishore, U, Strong, P, Aggrawal, S, Saram, PU, Reid, KBM 1997Binding of pulmonary surfactant protein A and D to Aspergillus fumigatus conidia enhance phagocytosis and killing by human neutrophils and alveolar macrophages.Infect Immun6531713179PubMed Madan, T, Eggleton, P, Kishore, U, Strong, P, Aggrawal, S, Saram, PU, Reid, KBM 1997Binding of pulmonary surfactant protein A and D to Aspergillus fumigatus conidia enhance phagocytosis and killing by human neutrophils and alveolar macrophages.Infect Immun6531713179PubMed
17.
go back to reference Mason, RJ, Nielsen, LD, Kuroki, Y, Matsuura, E, Freed, JH, Shannon, JM 1998A 50-kDa variant form of human surfactant protein D.Eur Respir J1211471155CrossRefPubMed Mason, RJ, Nielsen, LD, Kuroki, Y, Matsuura, E, Freed, JH, Shannon, JM 1998A 50-kDa variant form of human surfactant protein D.Eur Respir J1211471155CrossRefPubMed
18.
go back to reference Persson, A, Chang, D, Crouch, E 1990Surfactant protein D is a divalent cation-dependent carbohydrate-binding protein.J Biol Chem26557555760PubMed Persson, A, Chang, D, Crouch, E 1990Surfactant protein D is a divalent cation-dependent carbohydrate-binding protein.J Biol Chem26557555760PubMed
19.
go back to reference Pikaar, JC, Voorhut, WF, van Golde, LM, Verhoef, J, van Stijp, JA, van Iwaarden, JF 1995Opsonic activities of surfactant protein A and D in phagocytosis of gram-negative bacterias by alveolar macrophages.J Infect Dis172481489PubMed Pikaar, JC, Voorhut, WF, van Golde, LM, Verhoef, J, van Stijp, JA, van Iwaarden, JF 1995Opsonic activities of surfactant protein A and D in phagocytosis of gram-negative bacterias by alveolar macrophages.J Infect Dis172481489PubMed
20.
go back to reference Postle, AD, Mander, A, Reid, KBM, Wang, J-Y, Wright, SM, Moustaki, M, Warner, JO 1999Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis.Am J Respir Cell Mol Biol209098PubMed Postle, AD, Mander, A, Reid, KBM, Wang, J-Y, Wright, SM, Moustaki, M, Warner, JO 1999Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis.Am J Respir Cell Mol Biol209098PubMed
21.
go back to reference Reid, KBM 1998Interactions of surfactant protein D with pathogens, allergens and phagocytes.Biochem Biophys Acta1408290295CrossRefPubMed Reid, KBM 1998Interactions of surfactant protein D with pathogens, allergens and phagocytes.Biochem Biophys Acta1408290295CrossRefPubMed
22.
go back to reference Restrepo, CI, Dong, Q, Savov, J, Mariencheck, WI, Wright, JR 1999SP-D stimulates phagocytosis of Pseudomonas aeruginosa by alveolar macrophages.Am J Respir Cell Mol Biol21576585PubMed Restrepo, CI, Dong, Q, Savov, J, Mariencheck, WI, Wright, JR 1999SP-D stimulates phagocytosis of Pseudomonas aeruginosa by alveolar macrophages.Am J Respir Cell Mol Biol21576585PubMed
23.
go back to reference Rochat, T, Dayer Pastore, F, Schlegel-Haueter, SE, Filthuth, I, Auckenthaler, R, Belli, D, Suter, S 1996Aerosolized rhDNase in cystic fibrosis: effect on leukocyte proteases in sputum.Eur Respir J922002206CrossRefPubMed Rochat, T, Dayer Pastore, F, Schlegel-Haueter, SE, Filthuth, I, Auckenthaler, R, Belli, D, Suter, S 1996Aerosolized rhDNase in cystic fibrosis: effect on leukocyte proteases in sputum.Eur Respir J922002206CrossRefPubMed
24.
go back to reference Schoschett, P, Mora, R, Mark, L, Butler, M, Ingenito, EP 1999Calcium-dependent degradation of surfactant protein A by activated neutrophils due to serine proteases.Exp Lung Res25595616CrossRefPubMed Schoschett, P, Mora, R, Mark, L, Butler, M, Ingenito, EP 1999Calcium-dependent degradation of surfactant protein A by activated neutrophils due to serine proteases.Exp Lung Res25595616CrossRefPubMed
25.
go back to reference Strong, P, Kishore, U, Morgan, C, Lopez, BA, Singh, M, Reid, KBM 1998A novel method of purifying lung surfactant proteins A and D from the lung lavage of alveolar proteinosis patients and from pooled amniotic fluid.J Immunol Methods220139149CrossRefPubMed Strong, P, Kishore, U, Morgan, C, Lopez, BA, Singh, M, Reid, KBM 1998A novel method of purifying lung surfactant proteins A and D from the lung lavage of alveolar proteinosis patients and from pooled amniotic fluid.J Immunol Methods220139149CrossRefPubMed
26.
go back to reference Tsao, F, Meyer, K, Chen, X, Rosenthal, NS, Hu, J 1998Degradation of annexin I in bronchoalveolar lavage fluid from patients with cystic fibrosis.Am J Resp Cell Mol Biol18120128 Tsao, F, Meyer, K, Chen, X, Rosenthal, NS, Hu, J 1998Degradation of annexin I in bronchoalveolar lavage fluid from patients with cystic fibrosis.Am J Resp Cell Mol Biol18120128
27.
go back to reference von Bredow, C, Birrer, P, Griese, M 2001Degradation of surfactant protein A and other bronchoalveolar lavage fluid proteins in patients with cystic fibrosis.Eur Respir J17716722CrossRefPubMed von Bredow, C, Birrer, P, Griese, M 2001Degradation of surfactant protein A and other bronchoalveolar lavage fluid proteins in patients with cystic fibrosis.Eur Respir J17716722CrossRefPubMed
28.
go back to reference Whitsett, JA, Weaver, T, Hull, W, Ross, G, Dion, C 1985Synthesis of surfactant-associated glycoprotein A by rat type II epithelial cells. Primary translation products and post-translational modification.Biochem Biophys Acta828162171CrossRefPubMed Whitsett, JA, Weaver, T, Hull, W, Ross, G, Dion, C 1985Synthesis of surfactant-associated glycoprotein A by rat type II epithelial cells. Primary translation products and post-translational modification.Biochem Biophys Acta828162171CrossRefPubMed
29.
go back to reference Witko-Sarsat, V, Halbwachs-Mecarelli, L, Schuster, A, Nusbaum, P, Ucki, I, Canteloup, S, Lenoir, G, Descamps-Latscha, B, Nadel, JA 1999Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum.Am J Respir Cell Mol Biol20729736PubMed Witko-Sarsat, V, Halbwachs-Mecarelli, L, Schuster, A, Nusbaum, P, Ucki, I, Canteloup, S, Lenoir, G, Descamps-Latscha, B, Nadel, JA 1999Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum.Am J Respir Cell Mol Biol20729736PubMed
Metadata
Title
Proteolysis of Surfactant Protein D by Cystic Fibrosis Relevant Proteases
Authors
C. von Bredow
A. Wiesener
M. Griese
Publication date
01-05-2003
Publisher
Springer-Verlag
Published in
Lung / Issue 2/2003
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-003-1008-z

Other articles of this Issue 2/2003

Lung 2/2003 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine